This paper explores the relationship between investing in pharmaceutical manufacturing risk reduction and meeting business objectives.
David Lebo
Advertisement
David Lebo, PhD is Professor of Pharmaceutics, Temple University School of Pharmacy.
Articles by David Lebo
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
2
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
3
Everything to Know about BMS & NVidia’s AI Supercomputer
4
PharmTech Weekly Roundup—July 17, 2026
5